Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing-Reference-Cited by-同舟云学术

Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing

Published:2018-04-18 Issue:21 Volume:140 Page:6596-6603
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Rouet Romain,Thuma Benjamin A.¹,Roy Marc D.²,Lintner Nathanael G.³,Rubitski David M.²,Finley James E.²,Wisniewska Hanna M.¹,Mendonsa Rima,Hirsh Ariana,de Oñate Lorena,Compte Barrón Joan,McLellan Thomas J.¹,Bellenger Justin¹,Feng Xidong¹,Varghese Alison¹^ORCID,Chrunyk Boris A.¹,Borzilleri Kris¹,Hesp Kevin D.¹,Zhou Kaihong,Ma Nannan,Tu Meihua³,Dullea Robert⁴,McClure Kim F.³,Wilson Ross C.^ORCID,Liras Spiros³,Mascitti Vincent¹,Doudna Jennifer A.⁵^ORCID

Affiliation:

1. Pfizer Medicine Design, Groton, Connecticut 06340, United States

2. Pfizer Drug Safety R&D, Groton, Connecticut 06340, United States

3. Pfizer Medicine Design, Cambridge, Massachusetts 02139, United States

4. Pfizer CVMET Biology, Cambridge, Massachusetts 02139, United States

5. MBIB Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States

Funder

National Health and Medical Research Council

Pfizer

Publisher

American Chemical Society (ACS)

Subject